MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
The Lancet Infectious Diseases in conversation with - En podcast af The Lancet Group
Kategorier:
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
